指状突树突细胞肉瘤的特征及诊断治疗

doi:10.3760/cma.j.issn.1673-422X.2014.09.011

摘要/Abstract

摘要： 指状突树突细胞肉瘤（IDCS）是一种极罕见的造血组织来源的树突细胞恶性肿瘤，主要表现为浅表淋巴结肿大，也可以发生于肺脏、肾脏、膀胱、胸膜等不典型的部位。随着病理诊断水平提高、免疫组织化学及电镜的应用，该病诊断检出率明显升高。目前手术仍是该病治疗的主要手段，但由于疾病恶性程度高、进展迅速，具有不良的预后。

关键词: 树突状细胞肉瘤, 指突, 诊断, 治疗

Abstract: Interdigitating dendritic cell sarcoma (IDCS) is a rare malignant tumor of the dendritic cell, derived from the hematopoietic tissue. The major clinical manifestation of IDCS is superficial lymphadenopathy, and the enlarged lymph nodes may appear in some atypical ereas, such as the lung, kidney, bladder and the pleura, etc. With the development of the pathological diagnosis and the application of immunohistochemical staining and electron microscopes, the case detection rate is apparently improved. With the high degree of malignant, rapid progress and poor prognosis of the disease, currently, surgical therapy is still the main approach to the treatment of IDCS.

Key words: Dendritic cell sarcoma, interdigitating, Diagnosis, Therapy

李俊萍,赵如森,王永涛,李兵,张桂芝. 指状突树突细胞肉瘤的特征及诊断治疗[J]. 国际肿瘤学杂志, 2014, 41(8): 675-678.

Li Junping, Zhao Rusen, Wang Yongtao, Li Bing, Zhang Guizhi. Characteristics, diagnosis and treatment of interdigitating dendritic cell sarcoma[J]. Journal of International Oncology, 2014, 41(8): 675-678.

参考文献

［1］ Pileri SA, Grogan TM, Harris NL, et al. Tumours of Histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases［J］. Histopathol, 2002, 41(1): 1-29. ［2］ Kanaan H, AlMaghrabi J, Linjawi A, et al. Interdigitating dendritic cell sarcoma of the duodenum with rapidly fatal course: a case report and review of the literature［J］. Arch Pathol Lab Med, 2006, 130(2): 205-208. ［3］ Kadowaki N. The divergence and interplay between pDC and mDC in humans［J］. Front Biosci (Landmark Ed), 2009, 14: 808-817. ［4］ Feltkamp CA, Van Heerde P, FeltkampVroom TM, et al. A malignant tumor arising from interdigitating cells; light microscopical, ultrastructural, immunoand enzymehistochemical characteristics ［J］. Virchows Arch A Pathol Anat Histol, 1981, 393(2): 183-192. ［5］徐位顿, 王卓才. 左腋窝淋巴结指状突树突状细胞肉瘤1例［J］. 广东医学, 2002, 23: 682. ［6］ Zhang J, Liu B, Song N, et al. Interdigitating dendritic cell sarcoma presenting in the kidney combined with retroperitoneal leiomyosarcoma: a case report and literature review［J］. Oncol Lett, 2014, 7(2): 466-470. ［7］ Ye Z, Liu F, Cao Q, et al. Interdigitating dendritic cell sarcoma of lymph node mimicking granuloma: a case report and review of the literature［J］. Pol J Pathol, 2011, 62（4）: 274-277. ［8］ Perkins SM, Shinohara ET. Interdigitating and follicular dendritic cell sarcomas: a SEER analysis［J］. Am J Clin Oncol, 2013, 36(4): 395-398. ［9］ Kawachi K, Nakatani Y, Inayama Y, et al. Interdigital dentritie cell sarcoma of the spleen: report of a case with a review of the literature［J］. Am J Surg Pathol, 2002, 26（4）： 530-537. ［10］张哉根, 叶明福, 刁鑫伟, 等. 淋巴结指状突树突细胞肉瘤临床病理观察［J］. 诊断病理学杂志, 2005, 57(1): 87-89. ［11］ Jiang YZ, Dong NZ, Wu DP, et al. Interdigitating dendritic cell sarcoma presenting simultaneously with acute myelomonocytic leukemia: report of a rare case and literature review［J］. Int J Hematol, 2013, 97(5): 657-666. ［12］ Porter DW, Gupte GL, Brown RM, et al. Histiocytic sarcoma with interdigitating dendritic cell differentiation［J］. J Pediatr Hematol Oncol, 2004, 26(12): 827-830. ［13］ Barwell N, Howatson R, Jackson R, et al. Interdigitating dendritic cell sarcoma of salivary gland associated lymphoid tissue not associated with HHV8 or EBV infection［J］. J Clin Pathol, 2004, 57(1): 87-89. ［14］ Nayer H, Murphy KM, Hawkins AL, et al. Clonal cytogenetic abnormalities and BCL2 rearrangement in interdigitating dendritic cell sarcoma［J］. Leuk Lymphoma, 2006, 47(12): 2651-2654. ［15］ Wang HY, Li S, Woodford RL, et al. BCL2 chromosomal translocation is not a general feature of the interdigitating dendritic cell sarcoma［J］. Diagn Mol Pathol, 2010, 19(3): 169-171. ［16］ Radovi′c S, Dori′c M, Zujo H, et al. Interdigitating dendritic cell sarcoma of the liver and lung: a case report with morphohological and immunohistochemical features of tumor［J］. Bosn J Basic Med Sci, 2012, 12(3): 203-206. ［17］ Han HS, Lee OJ, Lim SN, et al. Extranodal interdigitating dendritic cell sarcoma presenting in the pleura: a case report［J］. J Korean Med Sci, 2011, 26(2): 304-307. ［18］ Parada D, Peńa KB, Gil I, et al. Interdigitating dendritic cell sarcoma presenting in the nasal region［J］. Pathol Res Pract, 2012, 208(6): 368-371. ［19］ Zhang J, Liu B, Song N, et al. Interdigitating dendritic cell sarcoma presenting in the kidney combined with retroperitoneal leiomyosarcoma: a case report and literature review［J］. Oncol Lett, 2014, 7(2): 466-470. ［20］ Zhou J, Zhou W, Bai C, et al. Interdigitating dendritic cell sarcoma: case report with review of the literature［J］. Onkologie, 2011, 34(11): 634-637. ［21］ Fonseca R, Yamakawa M, Nakamura S, et al. Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review［J］. Am J Hematol, 1998, 59(2): 161-167. ［22］ Wu L, Liu YJ. Development of dendriticcell lineages［J］. Immunity, 2007, 26(6): 741-750. ［23］张秀茹, 陈桂秋, 于国, 等. 指状突树突细胞肉瘤2例临床病理观察［J］.诊断病理学杂志, 2010, 17(6): 431-434. ［24］吕翔, 王益华, 陈蕾, 等. 组织细胞肉瘤和树突细胞肿瘤的WHO分类介绍［J］. 临床与实验病理学杂志, 2005, 21(5): 525-528. ［25］ Wang H, Su Z, Hu Z, et al. Follicular dendritic cell sarcoma: a report of six cases and a review of the Chinese literature［J］. Diagn Pathol, 2010, 11(5): 67. ［26］ Sagransky MJ, Deng AC, Magro CM. Primary cutaneous langerhans cellsarcoma: a report of four cases and review of the literature［J］.Am J Dermatopathol, 2013, 35(2): 196-204. ［27］ Matushansky I, Charytonowicz E, Mills J, et al. MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century［J］. Expert Rev Anticancer Ther, 2009, 9(8): 1135-1144. ［28］ De Pas T, Spitaleri G, Pruneri G, et al. Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases［J］. Crit Rev Oncol Hematol, 2008, 65(1): 1-7. ［29］ Olnes MJ, Nicol T, Duncan M, et al. Interdigitating dendritic cell sarcoma: a rare malignancy responsive to ABVD chemotherapy［J］. Leuk Lymphoma, 2002, 43(4): 817-821. ［30］ Lee SY, Lee SR, Chang WJ, et al. Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy［J］. Korean J Hematol, 2012, 47(2): 150-153. ［31］ Kairouz S, Hashash J, Kabbara W, et al. Dendritic cell neoplasms: an overview［J］. Am J Hematol, 2007, 82（10）: 924-928. ［32］ Azim HA, Elsedewy E, Azim HA. Imatinib in the treatment of follicular dendritic sarcoma：a report and review of literature［J］．Onkologie, 2007, 30(7): 381-384．［33］ Shukla N, Kobos R, Renaud T, et al. Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab［J］. Cancer, 2012, 118(15): 3719-3724. ［34］ Saygin C, Uzunaslan D, Ozguroglu M, et al. Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series［J］. Crit Rev Oncol Hematol, 2013, 88(2): 253-271. ［35］ Han SW, Kim ZS, Kim HM, et al. Interdigitating dendritic cell sarcoma occured alone in axilla［J］. J Korean Surg Soc, 2012, 82(5): 330-334. ［36］ De Pas T, Spitaleri G, Pruneri G, et al. Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases［J］. Crit Rev Oncol Hematol, 2008, 65(1): 1-7.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	钱晓涛, 石子宜, 胡格, 吴晓维. Ⅲ~ⅣA期食管鳞状细胞癌放化疗后行巩固化疗的疗效：一项真实世界临床研究[J]. 国际肿瘤学杂志, 2024, 51(6): 326-331.
[3]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[4]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[5]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[6]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[7]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[8]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.
[9]	陈琦, 徐晨阳, 王寅, 雷大鹏. 高光谱成像在头颈部肿瘤诊疗中的应用现状[J]. 国际肿瘤学杂志, 2024, 51(5): 298-302.
[10]	王培鑫, 赵军, 徐世红, 姜朝阳, 王小强, 杨红娟. 铁死亡相关机制在骨肉瘤中的应用进展[J]. 国际肿瘤学杂志, 2024, 51(5): 308-311.
[11]	王昆, 周中新, 臧其威. 血清TGF-β1、VEGF水平对非小细胞肺癌患者单孔胸腔镜根治术后复发的预测价值[J]. 国际肿瘤学杂志, 2024, 51(4): 198-203.
[12]	萨蔷, 徐航程, 王佳玉. 乳腺癌免疫治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 227-234.
[13]	杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙. 肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238.
[14]	王子豪, 王宇, 杨鑫, 何艺, 莫兴奎, 袁涛. 铁死亡在骨肉瘤中的分子机制及相关治疗的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 239-244.
[15]	张栋岩, 王品, 魏秋亚, 邓成伍, 魏相相, 高远飞, 王琛. 索凡替尼靶向联合卡培他滨和奥沙利铂治疗肝内胆管癌术后患者1例及文献复习[J]. 国际肿瘤学杂志, 2024, 51(4): 249-253.